Sanofi (SNY) Other Operating Expenses (2009 - 2026)

Sanofi has disclosed Other Operating Expenses across 8 years of filings, most recently posting -$1.4 billion for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 60.15% year-over-year to -$1.4 billion; the TTM figure through Jun 2026 stood at -$10.3 billion (down 88.23% YoY), while the FY2025 annual figure was -$5.1 billion, down 43.96% from the prior year.
• Other Operating Expenses came in at -$1.4 billion for Q1 2026 at Sanofi, up from -$5.1 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$656.2 million in Q1 2024 to a low of -$5.1 billion in Q4 2025.
• Average Other Operating Expenses over 4 years is -$2.4 billion, with a median of -$2.0 billion recorded in 2026.
• Year-over-year, Other Operating Expenses slumped 32.57% in 2024 and slumped 247.97% in 2025.
• Over 4 years, Other Operating Expenses stood at -$2.7 billion in 2023, then tumbled by 32.57% to -$3.5 billion in 2024, then slumped by 45.81% to -$5.1 billion in 2025, then jumped by 72.95% to -$1.4 billion in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$1.4 billion in Q1 2026, -$5.1 billion in Q4 2025, and -$3.8 billion in Q3 2025.